Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Vanessa Raymont

MBChB MSc MRCPsych


Senior Clinical Researcher Director, Oxford Brain Health Clinical Trials Unit

  • Honorary Senior Clinical Research Fellow, Centre of Dementia Prevention, University of Edinburgh
  • Honorary Consultant Psychiatrist

My clinical and research interests are in traumatic brain injury, and memory disorders and dementia, as well as clinical trials in cognitive impairment, having worked for over 20 years in clinical trials in the UK and US. 

I am currently the Principal Investigator for the Oxford site of the EPAD (European Prevention of Alzheimer’s Dementia) longitudinal cohort study, New Therapeutics in Alzheimer’s Disease (NTAD), Brains for Dementia Research (BDR) and 7Tesla MRI Scanning in Alzheimer’s disease and Frontotemporal Lobar Degeneration studies and Chief Investigator on the  Deep and Frequent Phenotyping (DFP) and MIcroglial CSF1R in Alzheimer’s Disease (MICAD) studies. I am co-lead for the Clinical Trials section of Oxford Translational Neuroscience and Dementia Research Group and NIHR Dementia and Mental Health Lead for the Thames Valley and South Midlands Clinical Research Network. I am an associate director of Dementia Platforms UK, and workstream lead for the Trials Delivery Framework.

Recent publications

More publications